{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T16:00:15Z","timestamp":1775750415282,"version":"3.50.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.01428","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T14:01:32Z","timestamp":1561125692000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Characteristics of 1946 Cases of POEMS Syndrome in Chinese Subjects: A Literature-Based Study"],"prefix":"10.3389","volume":"10","author":[{"given":"Yong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Bo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Qing","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1212\/WNL.34.6.712","article-title":"The Crow-Fukase syndrome: a study of 102 cases in Japan","volume":"34","author":"Nakanishi","year":"1984","journal-title":"Neurology."},{"key":"B2","first-page":"543","article-title":"Plasma cell dyscrasia with polyneuropathy and endocrine disorder: clinical and laboratory features of 109 reported cases","volume":"13","author":"Takatsuki","year":"1983","journal-title":"Jpn. J. Clin. Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ajh.24356","article-title":"Long-term outcome of patients with POEMS syndrome: an update of the Mayo Clinic experience","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am J Hematol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltimore)."},{"key":"B5","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017 update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01762445","article-title":"Myelom und nervensystem: uber eine bisher nicht beschrieben mit eigentumlichen Hautveranderungen einhergehende Polyneuritis bei einem plamazellularen Myelom des Sternums","volume":"147","author":"Scheinker","year":"1938","journal-title":"Dtsch Z Nervenheilkd."},{"key":"B7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1136\/bmj.2.4996.802","article-title":"Peripheral neuritis in myelomatosis","volume":"2","author":"Crow","year":"1956","journal-title":"Br Med J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp-2011-301706","article-title":"Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"83","author":"Nasu","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","article-title":"POEMS syndrome: a study of 25 cases and a review of the literature","volume":"97","author":"Soubrier","year":"1994","journal-title":"Am J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1182\/blood-2002-07-2299","article-title":"POEMS syndrome: definitions and long- term outcome","volume":"101","author":"Dispenzieri","year":"2003","journal-title":"Blood."},{"key":"B11","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jocn.2010.07.124","article-title":"Clinicopathological profile of polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome","volume":"18","author":"Kulkarni","year":"2011","journal-title":"J Clin Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00277-010-1149-0","article-title":"Clinical characteristics and long-term outcome of patients with POEMS syndrome in China","volume":"90","author":"Li","year":"2011","journal-title":"Ann Hematol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/leu.2016.168","article-title":"Prognostic study for overall survival in patients with newly diagnosed POEMS syndrome","volume":"31","author":"Wang","year":"2017","journal-title":"Leukemia."},{"key":"B14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.leukres.2016.09.017","article-title":"Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome","volume":"50","author":"Wang","year":"2016","journal-title":"Leuk Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/bjh.12236","article-title":"New advances in the diagnosis and treatment of POEMS syndrome","volume":"161","author":"Li","year":"2013","journal-title":"Br J Haematol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/(SICI)1097-4598(199811)21:11<1390::AID-MUS5>3.3.CO;2-S","article-title":"Overproduction of vascular endothelial growth factor\/vascular permeability factor is causative in Crow\u2013Fukase (POEMS) syndrome","volume":"21","author":"Watanabe","year":"1998","journal-title":"Muscle Nerve"},{"key":"B17","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(96)91261-1","article-title":"Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome","volume":"347","author":"Watanabe","year":"1996","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1182\/blood-2011-06-362392","article-title":"The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome","volume":"118","author":"D'Souza","year":"2011","journal-title":"Blood."},{"key":"B19","first-page":"84","article-title":"Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome","volume":"39","author":"Arimura","year":"1999","journal-title":"Rinsho shinkeigaku"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1093\/brain\/awh519","article-title":"Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis","volume":"128","author":"Scarlato","year":"2005","journal-title":"Brain."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e009157","DOI":"10.1136\/bmjopen-2015-009157","article-title":"Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study","volume":"5","author":"Misawa","year":"2015","journal-title":"BMJ Open."},{"key":"B22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2169\/internalmedicine.46.6246","article-title":"Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome","volume":"46","author":"Kanai","year":"2007","journal-title":"Intern Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1182\/blood-2005-12-5045","article-title":"Bevacizumab therapy for POEMS syndrome","volume":"107","author":"Straume","year":"2006","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/jnnp-2012-304874","article-title":"Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome","volume":"84","author":"Sekiguchi","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s00415-018-9068-4","article-title":"An updates on the diagnosis and management of the polyneuropathy of POEMS syndrome","volume":"266","author":"Cerri","year":"2018","journal-title":"J Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.hoc.2017.09.011","article-title":"POEMS syndrome: therapeutic options","volume":"32","author":"Jaccard","year":"2018","journal-title":"Hematol Oncol Clin North Am."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/S1474-4422(16)30176-4","article-title":"Thalidomide and POEMS syndrome: a cautious step forward","volume":"15","author":"Jaccard","year":"2016","journal-title":"Lancet Neurol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood."},{"key":"B29","first-page":"ECR02","article-title":"Restricted use of Vlambda genes in POEMS. syndrome","volume":"89","author":"Soubrier","year":"2004","journal-title":"Haematologica"},{"key":"B30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1182\/blood-2007-12-126979","article-title":"Restrictive usage of monoclonal immunoglobulin lambda light chain germline in POEMS syndrome","volume":"112","author":"Abe","year":"2008","journal-title":"Blood."},{"key":"B31","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood.V112.11.2744.2744","article-title":"Immunoglobulin variable light chain restriction, cytokine expression and plasma cell-stromal cell interactions in POEMS syndrome patients","volume":"112","author":"Aravamudan","year":"2008","journal-title":"Blood."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00277-012-1455-9","article-title":"Characterization of immunoglobulin \u03bb light chain variable region (IGLV) gene and its relationship with clinical features in patients with POEMS syndrome","volume":"91","author":"Li","year":"2012","journal-title":"Ann Hematol."},{"key":"B33","first-page":"108","article-title":"A clinical analysis of 32 cases of POEMS syndrome","volume":"45","author":"Zhu","year":"2006","journal-title":"Chin J Inter Med."},{"key":"B34","first-page":"229","article-title":"The clinical study of POEMS syndrome in China","volume":"31","author":"Zhang","year":"2010","journal-title":"Neuroendocrinol Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1445-5994.2010.02172.x","article-title":"POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China","volume":"41","author":"Cui","year":"2011","journal-title":"Intern Med J."},{"key":"B36","unstructured":"Polyneuropathy accompanied by impotence, edema and lymphadenopathy5702 BoQC WenBX China J Inter Med.251986"},{"key":"B37","first-page":"81","article-title":"POEMS syndrome with glomeruloid haemangioma: a case report","volume":"15","author":"Chan","year":"2007","journal-title":"Hong Kong J Dermatol Venereol."},{"key":"B38","first-page":"66","article-title":"Peripheral neuropathy: clinical diagnosis of POEMS syndrome and treatment with radiotherapy","volume":"10","author":"Ng","year":"2007","journal-title":"J Hong Kong Coll Radiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1212\/WNL.0000000000003405","article-title":"Clinical spectrum of Castleman disease-associated neuropathy","volume":"87","author":"Naddaf","year":"2016","journal-title":"Neurology."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3109\/10428190903324236","article-title":"Thyroid function and its clinical significance in POEMS syndrome","volume":"50","author":"Dun","year":"2009","journal-title":"Leuk Lymphoma."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1136\/jnnp.2008.150177","article-title":"Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome","volume":"79","author":"Kuwabara","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B42","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/ajh.23644","article-title":"POEMS syndrome: update on diagnosis, risk-stratification, and Management","volume":"89","author":"Dispenzieri","year":"2014","journal-title":"Am J Hematol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/asheducation-2005.1.360","article-title":"POEMS syndrome","volume":"1","author":"Dispenzieri","year":"2005","journal-title":"Hematology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1517\/14656566.6.6.945","article-title":"Treatment options for POEMS syndrome","volume":"6","author":"Dispenzieri","year":"2005","journal-title":"Expert Opin Pharmacother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/WCO.0000000000000610","article-title":"POEMS syndrome","volume":"31","author":"Keddie","year":"2018","journal-title":"Curr Opin Neurol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00330-014-3428-y","article-title":"Computed tomography assessment of bone lesions in patients with POEMS syndrome","volume":"25","author":"Glazebrook","year":"2015","journal-title":"Eur Radiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1182\/blood-2010-11-316935","article-title":"Bone marrow histopathology in POEMS syndrome: a distinctive combination of plasma cell, lymphoid and myeloid findings in 87 patients","volume":"117","author":"Dao","year":"2011","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/mus.21872","article-title":"Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias","volume":"43","author":"Briani","year":"2011","journal-title":"Muscle Nerve."},{"key":"B49","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.ejrad.2009.06.004","article-title":"18F-FDG PET\/CT in the evaluation of POEMS syndrome","volume":"76","author":"Alberti","year":"2010","journal-title":"Eur J Radiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1212\/01.wnl.0000344569.13496.ff","article-title":"Serum VEGF levels in POEMS syndrome and in immune-mediated neuropathies","volume":"72","author":"Nobile-Orazio","year":"2009","journal-title":"Neurology."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e486","DOI":"10.1212\/NXI.0000000000000486","article-title":"Raised VEGF: high sensitivity and specificity in the diagnosis of POEMS syndrome","volume":"5","author":"Pihan","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.hoc.2017.09.010","article-title":"POEMS syndrome: diagnosis and investigative work-up","volume":"32","author":"Dispenzieri","year":"2018","journal-title":"Hematol Oncol Clin North Am."},{"key":"B53","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/00005792-199607000-00005","article-title":"Acutearterial obliteration: a new feature of the POEMS syndrome?","volume":"75","author":"Lesprit","year":"1996","journal-title":"Medicine."},{"key":"B54","doi-asserted-by":"publisher","first-page":"89406","DOI":"10.18632\/oncotarget.20131","article-title":"Ischemic stroke in patients with POEMS syndrome: a case report and comprehensive analysis of literature","volume":"8","author":"Fu","year":"2017","journal-title":"Oncotarget"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1212\/WNL.0000000000001565","article-title":"Polyneuropathy improvement following autologous stem cell transplantation for POEMS syndrome","volume":"84","author":"Karam","year":"2015","journal-title":"Neurology."},{"key":"B56","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3324\/haematol.2016.148460","article-title":"High-dose therapy and autologous stem cell trans- plantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow Transplantation","volume":"102","author":"Cook","year":"2017","journal-title":"Haematologica."},{"key":"B57","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1600-0609.2008.01037.x","article-title":"Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome","volume":"80","author":"Dispenzieri","year":"2008","journal-title":"Eur J Haematol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.3109\/10428194.2013.869329","article-title":"Lenalidomide in patients with POEMS syndrome: a systematic review and pooled analysis","volume":"55","author":"Zagouri","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","article-title":"Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomized, double-blind, placebo-controlled trial","volume":"15","author":"Misawa","year":"2016","journal-title":"Lancet Neurol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/MAJ.0000000000000257","article-title":"Intractable ascites, changes in serum vascular endothelial growth factor levels and thalidomide treatment in POEMS syndrome","volume":"347","author":"Wu","year":"2014","journal-title":"Am J Med Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bjh.14966","article-title":"Lenalidomide and dexamethasone in patients with POEMS syndrome:results of a prospective, open label-trial","volume":"179","author":"Nozza","year":"2017","journal-title":"Br J Haematol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3109\/10428194.2014.974595","article-title":"Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients","volume":"56","author":"Lestang","year":"2015","journal-title":"Leuk Lymphoma."},{"key":"B63","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/bjh.14497","article-title":"Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen","volume":"181","author":"He","year":"2017","journal-title":"Br J Haematol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1600-0609.2012.01780.x","article-title":"Successful use of cyclophosphamide, bortezomib, and dexamethasone to treat a case of relapsed POEMS","volume":"88","author":"Warsame","year":"2012","journal-title":"Eur J Haematol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/leu.2017.68","article-title":"Validation of a prognostic score for patients with POEMS syndrome: a mayo clinic cohort","volume":"31","author":"Kourelis","year":"2017","journal-title":"Leukemia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/practneurol-2017-001792","article-title":"POEMS neuropathy: optimising diagnosis and management","volume":"18","author":"Keddie","year":"2018","journal-title":"Pract Neurol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01428\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T04:55:05Z","timestamp":1609995305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.01428\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2019.01428"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.01428","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"article-number":"1428"}}